Endotherapeutics is delighted to announce its recent partnership with inomed Medizintechnik GmbH, as their distributor for the C2 Xplore Intraoperative Neuromonitoring solution for OHNS and Thyroid procedures in Australia and New Zealand. We are excited to add the ground-breaking inomed technology to our current OHNS offering, and we are confident that this partnership will be a significant milestone in improving patient outcomes.
Based in Germany, inomed has been producing and developing medical technologies since 1991, with a focus on providing effective patient outcomes. The company collaborates with clinical innovation leaders worldwide and conducts extensive research and development to achieve this goal. inomed has achieved significant pioneering work, particularly with the introduction of the first nerve monitoring systems in 1992, which has helped to set further milestones in the medical industry. Today, their state-of-the-art devices are distributed in nearly 90 countries, providing complete intraoperative solutions with the aim of preventing nerve damage during surgical interventions, improving patient outcomes during and after operations, and enhancing the postoperative quality of life.
The high-quality and innovative inomed products have been used by more than 4,000 clinics worldwide, benefiting around 500,000 patients and doctors every year. We are excited to offer these exceptional products in Australia and continue to uphold our commitment to delivering the latest, most advanced medical solutions to improve patient outcomes.
